AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69
INHIBITION OF PANCREATIC TUMOR-CELL GROWTH IN CULTURE BY P21(WAF1) RECOMBINANT ADENOVIRUS
Authors: JOSHI US DERGHAM ST CHEN YQ DUGAN MC CRISSMAN JD VAITKEVICIUS VK SARKAR FH
Citation: Us. Joshi et al., INHIBITION OF PANCREATIC TUMOR-CELL GROWTH IN CULTURE BY P21(WAF1) RECOMBINANT ADENOVIRUS, Pancreas, 16(2), 1998, pp. 107-113
APOPTOSIS-TARGETED PROSTATE-CANCER DRUG DEVELOPMENT - SYNTHESIS OF A NOVEL CLASS OF CYCLIC HYDROXAMIC ACID WITH POTENT ANTIPROSTATE CANCER EFFECT IN-VITRO AND IN-VIVO
Authors: TANG DG ZHU ZY LI L JOSHI B JOHNSON C MARNETT L HONN KV CRISSMAN JD PONTES JS PORTER A
Citation: Dg. Tang et al., APOPTOSIS-TARGETED PROSTATE-CANCER DRUG DEVELOPMENT - SYNTHESIS OF A NOVEL CLASS OF CYCLIC HYDROXAMIC ACID WITH POTENT ANTIPROSTATE CANCER EFFECT IN-VITRO AND IN-VIVO, The Journal of urology, 159(5), 1998, pp. 497-497
RECOMMENDATIONS FOR THE REPORTING OF URINARY-BLADDER SPECIMENS CONTAINING BLADDER NEOPLASMS
Authors: FECHNER RE MURPHY WM CRISSMAN JD JOHANSSON SL AYALA AG
Citation: Re. Fechner et al., RECOMMENDATIONS FOR THE REPORTING OF URINARY-BLADDER SPECIMENS CONTAINING BLADDER NEOPLASMS, Pathology international, 47(5), 1997, pp. 329-331
EVALUATION OF MYC AND CHROMOSOME-8 COPY NUMBER IN BREAST-CARCINOMA BYINTERPHASE CYTOGENETICS
Authors: VISSCHER DW WALLIS T AWUSSAH S MOHAMED A CRISSMAN JD
Citation: Dw. Visscher et al., EVALUATION OF MYC AND CHROMOSOME-8 COPY NUMBER IN BREAST-CARCINOMA BYINTERPHASE CYTOGENETICS, Genes, chromosomes & cancer, 18(1), 1997, pp. 1-7
MOLECULAR-GENETIC ANALYSIS IN THE PATHOLOGICAL EVALUATION OF SOLID TUMORS - THEORY AND PRACTICE
Authors: VISSCHER DW SARKAR FH CRISSMAN JD
Citation: Dw. Visscher et al., MOLECULAR-GENETIC ANALYSIS IN THE PATHOLOGICAL EVALUATION OF SOLID TUMORS - THEORY AND PRACTICE, Journal of clinical laboratory analysis, 11(1), 1997, pp. 10-16
HER-2 NEU EXPRESSION IN PANCREATIC ADENOCARCINOMA - RELATION TO TUMORDIFFERENTIATION AND SURVIVAL/
Authors: DUGAN MC DERGHAM ST KUCWAY R SINGH K BIERNAT L DU W VAITKEVICIUS VK CRISSMAN JD SARKAR FH
Citation: Mc. Dugan et al., HER-2 NEU EXPRESSION IN PANCREATIC ADENOCARCINOMA - RELATION TO TUMORDIFFERENTIATION AND SURVIVAL/, Pancreas, 14(3), 1997, pp. 229-236
RELATIONSHIP OF FAMILY CANCER HISTORY TO THE EXPRESSION OF P53, P21(WAF-1), HER-2 NEU, AND K-RAS MUTATION IN PANCREATIC ADENOCARCINOMA/
Authors: DERGHAM ST DUGAN MC ARLAUSKAS P DU W VAITKEVICIUS VK CRISSMAN JD SARKAR FH
Citation: St. Dergham et al., RELATIONSHIP OF FAMILY CANCER HISTORY TO THE EXPRESSION OF P53, P21(WAF-1), HER-2 NEU, AND K-RAS MUTATION IN PANCREATIC ADENOCARCINOMA/, International journal of pancreatology, 21(3), 1997, pp. 225-234
PREVALENCE AND CLINICAL-SIGNIFICANCE OF COMBINED K-RAS MUTATION AND P53 ABERRATION IN PANCREATIC ADENOCARCINOMA
Authors: DERGHAM ST DUGAN MC KUCWAY R DU W KAMARAUSKIENE DS VAITKEVICIUS VK CRISSMAN JD SARKAR FH
Citation: St. Dergham et al., PREVALENCE AND CLINICAL-SIGNIFICANCE OF COMBINED K-RAS MUTATION AND P53 ABERRATION IN PANCREATIC ADENOCARCINOMA, International journal of pancreatology, 21(2), 1997, pp. 127-143
DNA-PLOIDY AND SYNTHESIS PHASE FRACTION (SPF) ANALYSIS OF 538 FRESH PROSTATE CANCERS (PCA) - CORRELATION WITH PATHOLOGICAL PARAMETERS AND BIOCHEMICAL RECURRENCE (BR)
Authors: JIMENEZ R SAKR WA GRIGNON DJ GINGRICH D TABACZKA P SWIRIDUK M CRISSMAN JD
Citation: R. Jimenez et al., DNA-PLOIDY AND SYNTHESIS PHASE FRACTION (SPF) ANALYSIS OF 538 FRESH PROSTATE CANCERS (PCA) - CORRELATION WITH PATHOLOGICAL PARAMETERS AND BIOCHEMICAL RECURRENCE (BR), Laboratory investigation, 76(1), 1997, pp. 444-444
ANALYSIS OF 3300 CONSECUTIVE PROSTATE BIOPSIES (PBX) - A 4 YEAR INSTITUTIONAL EXPERIENCE WITH THE FREQUENCY OF CARCINOMA (PCA), ISOLATED HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (HGPIN) AND ATYPICAL.
Authors: KHAN W SAKR WA GRIGNON DJ VANLUE C CRISSMAN JD
Citation: W. Khan et al., ANALYSIS OF 3300 CONSECUTIVE PROSTATE BIOPSIES (PBX) - A 4 YEAR INSTITUTIONAL EXPERIENCE WITH THE FREQUENCY OF CARCINOMA (PCA), ISOLATED HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (HGPIN) AND ATYPICAL., Laboratory investigation, 76(1), 1997, pp. 450-450
REFINED PATHOLOGICAL STAGING IS A POWERFUL PREDICTOR OF OUTCOME FOR PATIENTS WITH CLINICALLY LOCALIZED PROSTATE-CANCER (PCA)
Authors: SAKR WA GRIGNON DJ LOVISOLO J BANERJEE M WOOD D POWELL IJ PONTES JE CRISSMAN JD
Citation: Wa. Sakr et al., REFINED PATHOLOGICAL STAGING IS A POWERFUL PREDICTOR OF OUTCOME FOR PATIENTS WITH CLINICALLY LOCALIZED PROSTATE-CANCER (PCA), Laboratory investigation, 76(1), 1997, pp. 505-505
GLEASON SCORE-VII PROSTATE-CANCER (PCA), A HETEROGENEOUS ENTITY - CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS AND BIOCHEMICAL RECURRENCE
Authors: SAKR WA GRIGNON DJ SWIRIDUK M LITTRUP P WOOD D CHER M POWELL II PONTES JE CRISSMAN JD
Citation: Wa. Sakr et al., GLEASON SCORE-VII PROSTATE-CANCER (PCA), A HETEROGENEOUS ENTITY - CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS AND BIOCHEMICAL RECURRENCE, Laboratory investigation, 76(1), 1997, pp. 506-506
DOES THE EXTENT OF TUMOR INVOLVEMENT OF SURGICAL MARGINS OR THE AMOUNT OF EXTRAPROSTATIC TUMOR IN THE RADICAL PROSTATECTOMY (RP) SPECIMEN CORRELATE WITH BIOCHEMICAL RECURRENCE
Authors: VERNICK J SAKR WA GRIGNON DJ SWIRIDUK M WOOD D POWELL IJ PONTES JE BANERJEE M CRISSMAN JD
Citation: J. Vernick et al., DOES THE EXTENT OF TUMOR INVOLVEMENT OF SURGICAL MARGINS OR THE AMOUNT OF EXTRAPROSTATIC TUMOR IN THE RADICAL PROSTATECTOMY (RP) SPECIMEN CORRELATE WITH BIOCHEMICAL RECURRENCE, Laboratory investigation, 76(1), 1997, pp. 539-539
CONNEXIN-43 (CX-43) - A MARKER FOR EARLY NEOPLASTIC TRANSFORMATION INSQUAMOUS NEOPLASIA OF THE UPPER AERODIGESTIVE TRACT (UADT)
Authors: SAKR WA CRISSMAN JD SARKAR FH TABACZKA P KUCUK O BERTRRAM J
Citation: Wa. Sakr et al., CONNEXIN-43 (CX-43) - A MARKER FOR EARLY NEOPLASTIC TRANSFORMATION INSQUAMOUS NEOPLASIA OF THE UPPER AERODIGESTIVE TRACT (UADT), Laboratory investigation, 76(1), 1997, pp. 679-679
P21(WAF-1) (P21) EXPRESSION IN RELATED TO EARLY-STAGE AND INCREASED SURVIVAL WITH CONVENTIONAL THERAPIES IN PANCREATIC ADENOCARCINOMA
Authors: DERGHAM SD DUGAN MD DU W SMITH DW ARLAUSKAS P VAITKEVICUIS VK CRISSMAN JD SARKAR FH
Citation: Sd. Dergham et al., P21(WAF-1) (P21) EXPRESSION IN RELATED TO EARLY-STAGE AND INCREASED SURVIVAL WITH CONVENTIONAL THERAPIES IN PANCREATIC ADENOCARCINOMA, Laboratory investigation, 76(1), 1997, pp. 839-839
THE CLINICAL-SIGNIFICANCE OF P21(WAF1 CIP-1) AND P53 EXPRESSION IN PANCREATIC ADENOCARCINOMA/
Authors: DERGHAM ST DUGAN MC JOSHI US CHEN YC DU W SMITH DW ARLAUSKAS P CRISSMAN JD VAITKEVICIUS VK SARKAR FH
Citation: St. Dergham et al., THE CLINICAL-SIGNIFICANCE OF P21(WAF1 CIP-1) AND P53 EXPRESSION IN PANCREATIC ADENOCARCINOMA/, Cancer, 80(3), 1997, pp. 372-381
CORRELATION BETWEEN P53 IMMUNOSTAINING PATTERNS AND GENE SEQUENCE MUTATIONS IN BREAST-CARCINOMA
Authors: VISSCHER DW SARKAR FH SHIMOYAMA RK CRISSMAN JD
Citation: Dw. Visscher et al., CORRELATION BETWEEN P53 IMMUNOSTAINING PATTERNS AND GENE SEQUENCE MUTATIONS IN BREAST-CARCINOMA, Diagnostic molecular pathology, 5(3), 1996, pp. 187-193
TUMOR-SUPPRESSOR P53 GENE MUTATION IN SQUAMOUS-CELL CARCINOMA OF THE LARYNX
Authors: SARKAR FH SAKR WA LI YW JACOBS J CRISSMAN JD
Citation: Fh. Sarkar et al., TUMOR-SUPPRESSOR P53 GENE MUTATION IN SQUAMOUS-CELL CARCINOMA OF THE LARYNX, Diagnostic molecular pathology, 5(3), 1996, pp. 201-205
RECOMMENDATIONS FOR THE REPORTING OF URINARY-BLADDER SPECIMENS CONTAINING BLADDER NEOPLASMS
Authors: MURPHY WM CRISSMAN JD JOHANSSON SL AYALA AG
Citation: Wm. Murphy et al., RECOMMENDATIONS FOR THE REPORTING OF URINARY-BLADDER SPECIMENS CONTAINING BLADDER NEOPLASMS, Virchows Archiv, 428(1), 1996, pp. 1-3
CELL-CYCLE ANALYSIS OF NORMAL, ATROPHIC, AND HYPERPLASTIC BREAST EPITHELIUM USING 2-COLOR MULTIPARAMETRIC FLOW-CYTOMETRY
Authors: VISSCHER DW GINGRICH DS BUCKLEY J TABACZKA P CRISSMAN JD
Citation: Dw. Visscher et al., CELL-CYCLE ANALYSIS OF NORMAL, ATROPHIC, AND HYPERPLASTIC BREAST EPITHELIUM USING 2-COLOR MULTIPARAMETRIC FLOW-CYTOMETRY, Analytical cellular pathology, 12(2), 1996, pp. 115-124
RECOMMENDATIONS FOR THE REPORTING OF URINARY-BLADDER SPECIMENS THAT CONTAIN BLADDER NEOPLASMS
Authors: MURPHY WM CRISSMAN JD JOHANSSON SL AYALA AG
Citation: Wm. Murphy et al., RECOMMENDATIONS FOR THE REPORTING OF URINARY-BLADDER SPECIMENS THAT CONTAIN BLADDER NEOPLASMS, Modern pathology, 9(7), 1996, pp. 796-798
AGE AND RACIAL DISTRIBUTION OF PROSTATIC INTRAEPITHELIAL NEOPLASIA
Authors: SAKR WA GRIGNON DJ HAAS GP HEILBRUN LK PONTES JE CRISSMAN JD
Citation: Wa. Sakr et al., AGE AND RACIAL DISTRIBUTION OF PROSTATIC INTRAEPITHELIAL NEOPLASIA, European urology, 30(2), 1996, pp. 138-144
EVOLUTION OF THE TRANSITION ZONE OF THE PROSTATE-GLAND AND THE DEVELOPMENT OF BENIGN PROSTATIC HYPERPLASIA
Authors: SAKR WA MOYAD M HAAS GP GRIGNON DJ CASSIN BJ PONTES JE CRISSMAN JD
Citation: Wa. Sakr et al., EVOLUTION OF THE TRANSITION ZONE OF THE PROSTATE-GLAND AND THE DEVELOPMENT OF BENIGN PROSTATIC HYPERPLASIA, Laboratory investigation, 74(1), 1996, pp. 467-467
OVER-EXPRESSION OF ERBB2 GENE IN THE PROSTATE OF AFRICAN-AMERICAN (AA) AND CAUCASIAN (C) MEN
Authors: SARKAR FH GRIGNON DJ SAKR WA TABACZKA P CRISSMAN JD
Citation: Fh. Sarkar et al., OVER-EXPRESSION OF ERBB2 GENE IN THE PROSTATE OF AFRICAN-AMERICAN (AA) AND CAUCASIAN (C) MEN, Laboratory investigation, 74(1), 1996, pp. 469-469
MOLECULAR CLUES TO A NEW INTERPRETATION OF IN-SITU NEOPLASIA IN PANCREAS
Authors: DUGAN MC DERGHAM ST KUCWAY R VAITKEVICIUS VK CRISSMAN JD SARKAR FH
Citation: Mc. Dugan et al., MOLECULAR CLUES TO A NEW INTERPRETATION OF IN-SITU NEOPLASIA IN PANCREAS, Laboratory investigation, 74(1), 1996, pp. 781-781
Risultati: 1-25 | 26-50 | 51-69